v3.22.2.2
Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Disaggregation of Revenue [Line Items]        
Net sales $ 1,100.2 $ 1,042.7 $ 3,296.3 $ 3,033.8
CSCA        
Disaggregation of Revenue [Line Items]        
Net sales 722.3 694.2 2,160.2 1,957.0
CSCA | Upper Respiratory        
Disaggregation of Revenue [Line Items]        
Net sales 132.2 121.9 430.9 345.8
CSCA | Nutrition        
Disaggregation of Revenue [Line Items]        
Net sales 124.4 105.3 376.7 293.3
CSCA | Digestive Health        
Disaggregation of Revenue [Line Items]        
Net sales 119.6 110.6 363.3 344.0
CSCA | Pain and Sleep-Aids        
Disaggregation of Revenue [Line Items]        
Net sales 104.0 108.4 309.5 292.9
CSCA | Oral Care        
Disaggregation of Revenue [Line Items]        
Net sales 83.6 76.7 230.6 227.4
CSCA | Healthy Lifestyle        
Disaggregation of Revenue [Line Items]        
Net sales 73.8 72.1 208.7 213.0
CSCA | Skin Care        
Disaggregation of Revenue [Line Items]        
Net sales 48.9 46.4 138.4 139.1
CSCA | Women's Health        
Disaggregation of Revenue [Line Items]        
Net sales 12.4 10.4 32.6 28.7
CSCA | Vitamins, Minerals, and Supplements ("VMS")        
Disaggregation of Revenue [Line Items]        
Net sales 7.1 8.1 23.0 24.3
CSCA | Other CSCA        
Disaggregation of Revenue [Line Items]        
Net sales 16.3 34.3 46.5 48.5
CSCI        
Disaggregation of Revenue [Line Items]        
Net sales 377.9 348.5 1,136.1 1,076.8
CSCI | Upper Respiratory        
Disaggregation of Revenue [Line Items]        
Net sales 63.2 52.3 184.6 137.4
CSCI | Digestive Health        
Disaggregation of Revenue [Line Items]        
Net sales 4.1 5.7 13.3 15.5
CSCI | Pain and Sleep-Aids        
Disaggregation of Revenue [Line Items]        
Net sales 29.0 33.7 130.8 131.4
CSCI | Oral Care        
Disaggregation of Revenue [Line Items]        
Net sales 20.2 23.1 65.1 70.6
CSCI | Healthy Lifestyle        
Disaggregation of Revenue [Line Items]        
Net sales 25.0 37.1 105.4 134.5
CSCI | Skin Care        
Disaggregation of Revenue [Line Items]        
Net sales 132.4 114.2 342.1 304.3
CSCI | Women's Health        
Disaggregation of Revenue [Line Items]        
Net sales 29.9 13.4 67.3 42.1
CSCI | Vitamins, Minerals, and Supplements ("VMS")        
Disaggregation of Revenue [Line Items]        
Net sales 45.9 54.6 146.1 171.2
CSCI | Other CSCI        
Disaggregation of Revenue [Line Items]        
Net sales $ 28.2 $ 14.4 $ 81.4 $ 69.8